As we have seen in the US and all around the world, SARS-CoV-2, the virus that causes COVID-19, can cause severe complications and even death in many patients. In the early days of the pandemic, CIRM authorized $5 million in emergency funding for projects targeting the virus. To date CIRM has funded 20 projects related … Continue reading Study shows that COVID-19 vaccine is safe and effective in people with cancer

You can’t fix a global problem at the local level. That’s the gist of a new perspective piece in the journal Stem Cell Reports that calls for a global approach to rogue stem cell clinics that offer bogus therapies. The authors of the article are calling on the World Health Organization (WHO) to set up … Continue reading Call for a worldwide approach to regulating predatory stem cell clinics

Graphite Bio, a CIRM-catalyzed spinout from Stanford University that launched just 14 months ago has now filed the official SEC paperwork for an initial public offering (IPO). The company was formed by CIRM-funded researchers Matt Porteus, M.D., Ph.D. and Maria Grazia Roncarolo, M.D. Six years ago, Dr. Porteus and Dr. Roncarolo, in conjunction with Stanford … Continue reading CIRM-catalyzed spinout files for IPO to develop therapies for genetic diseases

Two voices, one message, watch out for predatory stem cell clinics Last week two new papers came out echoing each other about the dangers of bogus “therapies” being offered by predatory stem cell clinics and the risks they pose to patients. The first was from the Pew Charitable Trusts entitled: ‘Harms Linked to Unapproved Stem … Continue reading

According to the  National Organization for Rare Disorders (NORD), a disease is consider rare if it affects fewer than 200,000 people. If you combine the over 7,000 known rare diseases, about 30 million people in the U.S. are affected by one of these conditions. A majority of these conditions have no cure or have very … Continue reading CIRM funded trial may pave way for gene therapy to treat different diseases

Here’s a look at a couple of stories that caught our eye this week: Jasper Therapeutics has had a busy couple of weeks. Recently they announced data from their Phase 1 clinical trial treating people with Myelodysplastic syndromes (MDS). This is a group of disorders in which immature blood-forming cells in the bone marrow become … Continue reading Friday Round Up

Every year Bernie Siegel and his team at the World Stem Cell Summit (WSCS) put together a conference that highlights various topics in the stem cell and regenerative medicine field. This year, because of the coronavirus pandemic, the conference has adopted an entirely virtual format. The Virtual World Stem Cell Summit, as it is known, … Continue reading Join the World Stem Cell Summit for a virtual conference about stem cells and regenerative medicine

When someone scores a goal in soccer all the attention is lavished on them. Fans chant their name, their teammates pile on top in celebration, their agent starts calling sponsors asking for more money. But there’s often someone else deserving of praise too, that’s the player who provided the assist to make the goal possible … Continue reading Paving the Way

Earlier this week the CIRM ICOC Board awarded $14.5 million to fund three translational stage research projects (TRAN1), whose goal is to support early development activities necessary for advancement to a clinical study or broad end use of a potential therapy. Although all three projects have their distinct area of focus, they all utilize CAR-based … Continue reading Latest CIRM TRAN1 awards focus on CAR-based cell therapy to treat cancer